Literature DB >> 10348345

cDNA expression array reveals heterogeneous gene expression profiles in three glioblastoma cell lines.

C H Rhee1, K Hess, J Jabbur, M Ruiz, Y Yang, S Chen, A Chenchik, G N Fuller, W Zhang.   

Abstract

Tumor cell lines are an indispensable tool for cancer research. However, among cell lines of the same pathological group, heterogeneity has been detected in gene expression, gene mutation, and cellular response to various treatments. In this study, we systematically investigated the extent of heterogeneity of gene expression in three glioblastoma cell lines using cDNA array technology in which the expression of 588 cellular genes is studied simultaneously. Comparison of the expression profiles revealed substantial qualitative and quantitative heterogeneity. Among the 588 genes, 197 genes were expressed in all three lines and 56 genes were not expressed in any of the three lines; total of 222 genes were expressed in only two of the three cell lines, and 113 genes were expressed in only one of the three cell lines. These results provide molecular evidence that cell lines of the same pathological origin can be highly heterogeneous.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10348345     DOI: 10.1038/sj.onc.1202623

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Correlation between apoptosis microarray gene expression profiling and histopathological lymph node lesions.

Authors:  J P Dales; J Plumas; F Palmerini; E Devilard; T Defrance; A Lajmanovich; V Pradel; F Birg; L Xerri
Journal:  Mol Pathol       Date:  2001-02

2.  Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells.

Authors:  Q H Zhang; M Ye; X Y Wu; S X Ren; M Zhao; C J Zhao; G Fu; Y Shen; H Y Fan; G Lu; M Zhong; X R Xu; Z G Han; J W Zhang; J Tao; Q H Huang; J Zhou; G X Hu; J Gu; S J Chen; Z Chen
Journal:  Genome Res       Date:  2000-10       Impact factor: 9.043

3.  Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.

Authors:  Bethany L V Cuetara; Tania N Crotti; Anthony J O'Donoghue; Kevin P McHugh
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jul-Aug       Impact factor: 2.416

Review 4.  Perspectives of cellular and molecular neurosurgery.

Authors:  Manfred Westphal; Peter McL Black
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

5.  Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression.

Authors:  Nicholas A Shackel; Peter H McGuinness; Catherine A Abbott; Mark D Gorrell; Geoffrey W McCaughan
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

6.  Gene expression profiles in an hepatitis B virus transfected hepatoblastoma cell line and differentially regulated gene expression by interferon-alpha.

Authors:  Xun Wang; Zheng-Hong Yuan; Ling-Jie Zheng; Feng Yu; Wei Xiong; Jiang-Xia Liu; Gen-Xi Hu; Yao Li
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

Review 7.  Progress in the application of DNA microarrays.

Authors:  E K Lobenhofer; P R Bushel; C A Afshari; H K Hamadeh
Journal:  Environ Health Perspect       Date:  2001-09       Impact factor: 9.031

8.  Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method.

Authors:  E Smid-Koopman; L J Blok; S Chadha-Ajwani; T J Helmerhorst; A O Brinkmann; F J Huikeshoven
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

9.  Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines.

Authors:  Ho-Shin Gwak; Tae Hoon Kim; Guk Heui Jo; Youn-Jae Kim; Hee-Jin Kwak; Jong Heon Kim; Jinlong Yin; Heon Yoo; Seung Hoon Lee; Jong Bae Park
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells.

Authors:  Neža Podergajs; Helena Motaln; Uroš Rajčević; Urška Verbovšek; Marjan Koršič; Nina Obad; Heidi Espedal; Miloš Vittori; Christel Herold-Mende; Hrvoje Miletic; Rolf Bjerkvig; Tamara Lah Turnšek
Journal:  Oncotarget       Date:  2016-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.